Detalhe da pesquisa
1.
Application of counter-selectable marker PIGA in engineering designer deletion cell lines and characterization of CRISPR deletion efficiency.
Nucleic Acids Res
; 49(5): 2642-2654, 2021 03 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33591308
2.
Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria.
Eur J Haematol
; 108(5): 391-402, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35100459
3.
Analysis of platelets by flow cytometry in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
Blood Cells Mol Dis
; 80: 102372, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31710879
4.
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
Ann Hematol
; 99(7): 1505-1514, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32390114
5.
Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry.
Eur J Haematol
; 105(5): 561-570, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32640047
6.
MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
Haematologica
; 103(5): 830-839, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29449434
7.
Leukemic blasts with the paroxysmal nocturnal hemoglobinuria phenotype in children with acute lymphoblastic leukemia.
Am J Pathol
; 181(5): 1862-9, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22940070
8.
The rate of spontaneous mutations in human myeloid cells.
Mutat Res
; 749(1-2): 49-57, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23748046
9.
Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.
Haematologica
; 97(3): 344-52, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22133780
10.
Paroxysmal nocturnal hemoglobinuria in pediatric patients.
Pediatr Blood Cancer
; 59(3): 525-9, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22147651
11.
Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.
J Blood Med
; 13: 425-437, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35983240
12.
The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo.
Mutat Res
; 705(1): 3-10, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20034593
13.
A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene.
Mutat Res
; 686(1-2): 1-8, 2010 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20060400
14.
Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.
Am J Case Rep
; 21: e927418, 2020 Sep 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32917848
15.
No evidence of hypermutability in red cells from patients with paroxysmal nocturnal hemoglobinuria using the XK gene.
Haematologica
; 99(8): e142-4, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24816235
16.
Splenic infarction and subsequent splenic rupture in a patient with paroxysmal nocturnal hemoglobinuria and heparin-induced thrombocytopenia.
Pediatr Blood Cancer
; 53(3): 472-4, 2009 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-19415735
17.
Spontaneously arising red cells with a McLeod-like phenotype in normal donors.
Mutat Res
; 671(1-2): 1-5, 2009 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19909712
18.
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH).
Exp Hematol Oncol
; 8: 17, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31453016
19.
A quantitative measurement of the human somatic mutation rate.
Cancer Res
; 65(18): 8111-7, 2005 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16166284
20.
High incidence of thrombosis in African-American and Latin-American patients with Paroxysmal Nocturnal Haemoglobinuria.
Thromb Haemost
; 93(1): 88-91, 2005 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-15630496